DM
Deerfield Management Portfolio holdings
AUM
$7.8B
1-Year Est. Return
76.63%
This Fund
S&P 500
1 Year Est. Return
+76.63%
AUM
$6.52B
AUM Growth
+$1.02B
(+18%)
Holding
173
Top Buys
| 1 | +$177M | |
| 2 | +$109M | |
| 3 | +$96.7M | |
| 4 |
Inspire Medical Systems
INSP
|
+$91.9M |
| 5 |
Cogent Biosciences
COGT
|
+$76M |
Top Sells
| 1 | +$250M | |
| 2 | +$74.9M | |
| 3 | +$47.7M | |
| 4 |
IDEAYA Biosciences
IDYA
|
+$42.6M |
| 5 |
United Therapeutics
UTHR
|
+$38.6M |
Sector Composition
| 1 | Healthcare | 91.92% |
| 2 | Real Estate | 0.38% |
| 3 | Financials | 0.07% |
| 4 | Consumer Staples | 0.07% |
| 5 | Consumer Discretionary | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Nuvalent
NUVL
$7.87B
| $1.56B | 23.85% |
17,991,024
|
|
||
2
Centene
CNC
$21.9B
| $323M | 4.95% |
9,046,000
+5,860,630
|
|
||
|
MRUS
3
DELISTED
Merus
MRUS
| $287M | 4.4% |
3,046,916
-337,712
|
|
||
4
Viatris
VTRS
$18.1B
| $239M | 3.66% |
24,099,083
+75,176
|
|
||
|
5
United Therapeutics
UTHR
$22.1B
| $179M | 2.74% |
425,993
-114,633
|
|
||
6
Revolution Medicines
RVMD
$19.6B
| $170M | 2.61% |
3,650,342
+266,270
|
|
||
7
Indivior Pharmaceuticals
INDV
$4B
| $168M | 2.58% |
6,986,811
-3,580,349
|
|
||
8
Neurocrine Biosciences
NBIX
$13.3B
| $166M | 2.55% |
1,184,345
+16,543
|
|
||
|
9
Cogent Biosciences
COGT
$6.31B
| $130M | 1.99% |
9,053,118
+6,412,903
|
|
||
10
Ionis Pharmaceuticals
IONS
$13.3B
| $130M | 1.98% |
+1,979,669
|
|
||
11
NewAmsterdam Pharma
NAMS
$3.77B
| $121M | 1.86% |
4,266,693
-849,260
|
|
||
12
Vera Therapeutics
VERA
$2.87B
| $106M | 1.62% |
3,641,157
+293,040
|
|
||
13
Bristol-Myers Squibb
BMY
$127B
| $105M | 1.62% |
+2,337,771
|
|
||
14
AdaptHealth
AHCO
$1.31B
| $103M | 1.57% |
11,477,730
+1,572,835
|
|
||
15
Larimar Therapeutics
LRMR
$435M
| $98.9M | 1.52% |
30,606,974
+9,375,000
|
|
||
16
Brookdale Senior Living
BKD
$3.6B
| $98.6M | 1.51% |
11,641,642
-3,720,622
|
|
||
17
Catalyst Pharmaceutical
CPRX
$2.94B
| $98M | 1.5% |
4,974,767
+2,095,291
|
|
||
18
Legend Biotech
LEGN
$3.41B
| $96.6M | 1.48% |
2,962,338
|
|
||
19
BioCryst Pharmaceuticals
BCRX
$2.14B
| $92.4M | 1.42% |
12,169,000
+7,477,000
|
|
||
20
Merck
MRK
$300B
| $86.4M | 1.32% |
1,030,000
+172,276
|
|
||
21
Pfizer
PFE
$155B
| $84.2M | 1.29% |
3,303,790
-1,002,474
|
|
||
22
Certara
CERT
$1.12B
| $82.4M | 1.26% |
6,739,537
+2,813,438
|
|
||
|
23
Inspire Medical Systems
INSP
$1.85B
| $77.7M | 1.19% |
1,047,694
+907,694
|
|
||
24
ARS Pharmaceuticals
SPRY
$906M
| $75.4M | 1.16% |
7,503,812
-2,220,696
|
|
||
25
Insmed
INSM
$31.2B
| $67.8M | 1.04% |
471,000
-229,700
|
|